179 related articles for article (PubMed ID: 32694611)
1. Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion.
Kohno S; Linn P; Nagatani N; Watanabe Y; Kumar S; Soga T; Takahashi C
Oncogene; 2020 Aug; 39(34):5690-5707. PubMed ID: 32694611
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion.
Matilainen S; Isohanni P; Euro L; Lönnqvist T; Pihko H; Kivelä T; Knuutila S; Suomalainen A
Eur J Hum Genet; 2015 Mar; 23(3):325-30. PubMed ID: 24986829
[TBL] [Abstract][Full Text] [Related]
3. Two transgenic mouse models for β-subunit components of succinate-CoA ligase yielding pleiotropic metabolic alterations.
Kacso G; Ravasz D; Doczi J; Németh B; Madgar O; Saada A; Ilin P; Miller C; Ostergaard E; Iordanov I; Adams D; Vargedo Z; Araki M; Araki K; Nakahara M; Ito H; Gál A; Molnár MJ; Nagy Z; Patocs A; Adam-Vizi V; Chinopoulos C
Biochem J; 2016 Oct; 473(20):3463-3485. PubMed ID: 27496549
[TBL] [Abstract][Full Text] [Related]
4. Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients.
Carrozzo R; Verrigni D; Rasmussen M; de Coo R; Amartino H; Bianchi M; Buhas D; Mesli S; Naess K; Born AP; Woldseth B; Prontera P; Batbayli M; Ravn K; Joensen F; Cordelli DM; Santorelli FM; Tulinius M; Darin N; Duno M; Jouvencel P; Burlina A; Stangoni G; Bertini E; Redonnet-Vernhet I; Wibrand F; Dionisi-Vici C; Uusimaa J; Vieira P; Osorio AN; McFarland R; Taylor RW; Holme E; Ostergaard E
J Inherit Metab Dis; 2016 Mar; 39(2):243-52. PubMed ID: 26475597
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Sucla2 decreases the viability of mouse spermatocytes by inducing apoptosis through injury of the mitochondrial function of cells.
Huang S; Wang J; Wang L
Folia Histochem Cytobiol; 2016; 54(3):134-142. PubMed ID: 27766610
[TBL] [Abstract][Full Text] [Related]
6. Succinyl-CoA synthetase (SUCLA2) deficiency in two siblings with impaired activity of other mitochondrial oxidative enzymes in skeletal muscle without mitochondrial DNA depletion.
Huang X; Bedoyan JK; Demirbas D; Harris DJ; Miron A; Edelheit S; Grahame G; DeBrosse SD; Wong LJ; Hoppel CL; Kerr DS; Anselm I; Berry GT
Mol Genet Metab; 2017 Mar; 120(3):213-222. PubMed ID: 27913098
[TBL] [Abstract][Full Text] [Related]
7. Novel mutation in SUCLA2 identified on sequencing analysis.
Güngör O; Özkaya AK; Güngör G; Karaer K; Dilber C; Aydin K
Pediatr Int; 2016 Jul; 58(7):659-61. PubMed ID: 26952923
[TBL] [Abstract][Full Text] [Related]
8. Succinyl-CoA ligase ADP-forming subunit beta promotes stress granule assembly to regulate redox and drive cancer metastasis.
Boese AC; Kang J; Hwang JS; Kim J; Eun K; Malin CM; Magliocca KR; Pan C; Jin L; Kang S
Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2217332120. PubMed ID: 37253003
[TBL] [Abstract][Full Text] [Related]
9. SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells.
Tong Y; Guo D; Lin SH; Liang J; Yang D; Ma C; Shao F; Li M; Yu Q; Jiang Y; Li L; Fang J; Yu R; Lu Z
Mol Cell; 2021 Jun; 81(11):2303-2316.e8. PubMed ID: 33991485
[TBL] [Abstract][Full Text] [Related]
10. Disorders caused by deficiency of succinate-CoA ligase.
Ostergaard E
J Inherit Metab Dis; 2008 Apr; 31(2):226-9. PubMed ID: 18392745
[TBL] [Abstract][Full Text] [Related]
11. Exclusive neuronal expression of SUCLA2 in the human brain.
Dobolyi A; Ostergaard E; Bagó AG; Dóczi T; Palkovits M; Gál A; Molnár MJ; Adam-Vizi V; Chinopoulos C
Brain Struct Funct; 2015 Jan; 220(1):135-51. PubMed ID: 24085565
[TBL] [Abstract][Full Text] [Related]
12. A novel SUCLA2 mutation in a Portuguese child associated with "mild" methylmalonic aciduria.
Nogueira C; Meschini MC; Nesti C; Garcia P; Diogo L; Valongo C; Costa R; Videira A; Vilarinho L; Santorelli FM
J Child Neurol; 2015 Feb; 30(2):228-32. PubMed ID: 24659738
[TBL] [Abstract][Full Text] [Related]
13. SUCLA2 mutations cause global protein succinylation contributing to the pathomechanism of a hereditary mitochondrial disease.
Gut P; Matilainen S; Meyer JG; Pällijeff P; Richard J; Carroll CJ; Euro L; Jackson CB; Isohanni P; Minassian BA; Alkhater RA; Østergaard E; Civiletto G; Parisi A; Thevenet J; Rardin MJ; He W; Nishida Y; Newman JC; Liu X; Christen S; Moco S; Locasale JW; Schilling B; Suomalainen A; Verdin E
Nat Commun; 2020 Nov; 11(1):5927. PubMed ID: 33230181
[TBL] [Abstract][Full Text] [Related]
14. Screen for abnormal mitochondrial phenotypes in mouse embryonic stem cells identifies a model for succinyl-CoA ligase deficiency and mtDNA depletion.
Donti TR; Stromberger C; Ge M; Eldin KW; Craigen WJ; Graham BH
Dis Model Mech; 2014 Feb; 7(2):271-80. PubMed ID: 24271779
[TBL] [Abstract][Full Text] [Related]
15. Targeted Inhibition of the E3 Ligase SCF
Zhao H; Iqbal NJ; Sukrithan V; Nicholas C; Xue Y; Yu C; Locker J; Zou J; Schwartz EL; Zhu L
Cancer Res; 2020 Jun; 80(11):2355-2367. PubMed ID: 32265224
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations.
Ostergaard E; Hansen FJ; Sorensen N; Duno M; Vissing J; Larsen PL; Faeroe O; Thorgrimsson S; Wibrand F; Christensen E; Schwartz M
Brain; 2007 Mar; 130(Pt 3):853-61. PubMed ID: 17287286
[TBL] [Abstract][Full Text] [Related]
17. Co-occurring Down syndrome and SUCLA2-related mitochondrial depletion syndrome.
Couser NL; Marchuk DS; Smith LD; Arreola A; Kaiser-Rogers KA; Muenzer J; Pandya A; Gucsavas-Calikoglu M; Powell CM
Am J Med Genet A; 2017 Oct; 173(10):2720-2724. PubMed ID: 28749033
[TBL] [Abstract][Full Text] [Related]
18. PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells.
Itsumi M; Shiota M; Yokomizo A; Takeuchi A; Kashiwagi E; Dejima T; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
J Mol Endocrinol; 2014 Aug; 53(1):31-41. PubMed ID: 24780839
[TBL] [Abstract][Full Text] [Related]
19. A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer.
Tessem MB; Bertilsson H; Angelsen A; Bathen TF; Drabløs F; Rye MB
PLoS One; 2016; 11(4):e0153727. PubMed ID: 27100877
[TBL] [Abstract][Full Text] [Related]
20. The novel mutation p.Asp251Asn in the β-subunit of succinate-CoA ligase causes encephalomyopathy and elevated succinylcarnitine.
Jaberi E; Chitsazian F; Ali Shahidi G; Rohani M; Sina F; Safari I; Malakouti Nejad M; Houshmand M; Klotzle B; Elahi E
J Hum Genet; 2013 Aug; 58(8):526-30. PubMed ID: 23759946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
